Strand Strand Life Sciences Completes $13M Financing Round Private equity firm Quadria Capital led the investment round and was joined by HealthQuad Fund and Heritas Venture Fund. Venaxis, Strand Terminate Merger Plans The two companies, who announced the merger in January, said they could not complete the terms of their deal in a timely enough manner. UPDATE: Strand's India Laboratory Receives CAP, NABL Accreditations The Strand Center for Genomics and Personalized Medicine lab is now accredited in India to perform three of Strand's most popular tests. Venaxis Merges With Strand Life Sciences Once the deal is fully concluded, Strand's shareholders will own approximately 68 percent of the new company, while Venaxis shareholders will own 32 percent. Strand Aims to Push Cancer Sequencing Earlier in Patients' Disease Course Premium Strand provides a standard of care report that includes a handful of genes and IHC markers within eight days, and the full 152-gene report seven to 12 days later. Jun 29, 2015 ReadSense, Strand Life Sciences Ink Genetic Diseases Diagnostics Deal Jun 23, 2015 Tataa Biocenter to Distribute Strand's NGS Analysis Software in Europe Apr 15, 2015 Strand Life Sciences Opens Colorado CLIA Lab; Launches Tumor Sequencing Test Premium Mar 31, 2015 Strand Collaborates with MRI Global on Indian Reference Lab, CDx Nov 7, 2014 Leucine Rich Bio Prepares to Launch Clinical Genome Interpretation SaaS Offering Premium Jul 11, 2014 People in the News: Scott Storrer Premium Jul 3, 2014 Downloads and Upgrades: Strand NGS, Reactome Pathway Browser, and More Premium May 9, 2014 HealthCare Global's Triesta Unit Teams with Strand to Create Tumor Profiling, Oncology Testing Center Apr 4, 2014 Downloads and Upgrades: Strand Life Sciences, SMRTAnalysis 2.2, Illumina's BaseSpace, and more Premium Mar 28, 2014 IP Update: 23andMe, Strand Life Sciences among Recent Bioinformatics Patent Winners Premium Mar 25, 2014 Strand, BioHealth Partner to Expand Sequencing-based Diagnostic Services to US Jan 3, 2014 In 2013, Acquisitions, Clinical and Dx Applications Defined Bioinformatics Market Premium Dec 6, 2013 Codified Genomics Targets Clinical Testing Labs with Variant Interpretation Pipeline Premium Dec 5, 2013 Strand Partners with El Camino Hospital on Genomics Center Nov 22, 2013 In Brief This Week: Bio-Rad; Fitch, Abbott; Gentris; Indiana Biosciences Research Institute; Strand Life Sciences; Oncospire Genomics Nov 22, 2013 Strand Kicks Off EAP to Test Clinical Variant Interpretation and Reporting Software Premium Feb 15, 2013 Strand Secures $10M Series B Funding to Develop Clinical Genomics Infrastructure Premium Feb 11, 2013 Strand Gets Investment from Burrill Sep 21, 2012 In Brief This Week: Roche; Life Technologies; Trovagene, Strand; Fluidigm; Wellington Partners; Proteros, UCB; Evotec Jun 7, 2012 Dx Focus: Trovagene, Strand HPV MOU; Med Fusion, Roche Alliance; IMDx Gets Canadian Dx Licensure Premium Load More Breaking News In Ongoing False Advertising Suit, Judge Allows Natera Counterclaims Against Guardant Health Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution The Scan Transplant Tests Edited Pig Kidneys The Associated Press reports a University of Alabama-Birmingham team transplanted genetically modified pig kidneys into a brain-dead human patient. UK Changes Some Gene-Edited Crop Rules A new law may enable gene-edited crops to be sold in the UK within about five years, New Scientist says. Pill Works Against Omicron in Lab Pfizer's antiviral pill to treat SARS-CoV-2 appears to work against the Omicron variant, the Wall Street Journal reports. Nature Papers Find Genetic Risk Factor for Smell, Taste Loss in COVID-19; Analyze TB Granulomas In Nature this week: genome-wide association study find locus linked to the risk COVID-19 patients losing their sense of taste or smell, and more.